The biggest names in tech, e-commerce, and digital transformation are in the Nasdaq 100 (^NDX), but only a few are leading the pack. Some companies in this index are proving their resilience and expanding their competitive advantages.
The best Nasdaq 100 stocks don’t just grow - they dominate, and we’re here to help you find them. Keeping that in mind, here are three Nasdaq 100 stocks that have huge potential.
Apple (AAPL)
Market Cap: $4.34 trillion
Creator of the iPhone and App Store, Apple (NASDAQ: AAPL) is a legendary developer of consumer electronics and software.
Why Is AAPL Interesting?
- Apple’s revenue base is so large because nearly everyone in the U.S. has an iPhone, but this is a double-edged sword. Growth must now come from upgrades, a harder pitch that has resulted in sluggish top-line performance recently.
- Still, Apple’s devices have endured for decades, speaking to its brand, design ethos, and technological chops. Its success is rare in the world of consumer electronics, which is fraught because of commoditization, competition, and obsolescence risk.
- The company may not have the best gross margin because of its hardware orientation, but it still manages to produce elite operating and free cash flow margins. This shows it doesn’t need over-the-top marketing campaigns to convince people to buy its products.
Apple’s stock price of $308.47 implies a valuation ratio of 32.3x forward price-to-earnings. Is now the right time to buy? Find out in our full research report, it’s free.
Keurig Dr Pepper (KDP)
Market Cap: $42.49 billion
Born out of a 2018 merger between Keurig Green Mountain and Dr Pepper Snapple, Keurig Dr Pepper (NASDAQ: KDP) is a consumer staples powerhouse boasting a portfolio of beverages including sodas, coffees, and juices.
Why Could KDP Be a Winner?
- Products are reaching more households as its unit sales averaged 4.8% growth over the past two years
- Large revenue base of $16.94 billion and strong customer awareness make retailers more likely to stock its products
- Demand for the next 12 months is expected to accelerate above its three-year trend as Wall Street forecasts robust revenue growth of 72.3%
Keurig Dr Pepper is trading at $33.20 per share, or 14x forward P/E. Is now a good time to buy? See for yourself in our full research report, it’s free.
Amgen (AMGN)
Market Cap: $191.1 billion
Founded in 1980 during the early days of the biotechnology revolution, Amgen (NASDAQ: AMGN) is a biotechnology company that discovers, develops, and manufactures innovative medicines to treat serious illnesses like cancer, osteoporosis, and autoimmune diseases.
Why Are We Positive on AMGN?
- 12.3% annual revenue growth over the last two years surpassed the sector average as its offerings resonated with customers
- Revenue base of $37.22 billion gives it economies of scale and some negotiating power
- AMGN is a free cash flow machine with the flexibility to invest in growth initiatives or return capital to shareholders
At $373.23 per share, Amgen trades at 15.9x forward P/E. Is now the time to initiate a position? Find out in our full research report, it’s free.
Stocks We Like Even More
ONE MORE THING: Top 6 Stocks for This Week. This market is separating quality stocks from expensive ones fast. AI is taking down whole sectors with no warning. In a rotation this fast, you need more than a list of good companies.
Our AI system flagged Palantir before it ran 1,662%. AppLovin before it ran 753%. Nvidia before it ran 1,178%. Each week it produces 6 new names that pass the same tests. Get Our Top 6 Stocks for Free HERE.
Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,326% between June 2020 and June 2025) as well as under-the-radar businesses like the once-micro-cap company Kadant (+351% five-year return). Find your next big winner with StockStory today.
